SNNAQ OTC
Sienna Biopharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +9900.0%
1Y: +9900.0%
3Y: -0.0%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$157K
-30.8% ▼
Operating Income
-$76M
-57.5% ▼
Net Income
-$73M
-45.0% ▼
EPS (Diluted)
$-3.59
+30.8% ▲
EBITDA
-$76M
-57.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $32K | $67K | $120K | $157K |
| Gross Profit | -$32K | -$67K | -$120K | -$157K |
| Gross Margin | — | — | — | — |
| R&D Expenses | $2M | $11M | $30M | $52M |
| SG&A Expenses | $9M | $10M | $18M | $25M |
| Operating Expenses | $11M | $21M | $49M | $76M |
| Operating Income | -$11M | -$21M | -$49M | -$76M |
| Operating Margin | — | — | — | — |
| Interest Expense | $547K | $568K | $0 | $0 |
| Income Before Tax | -$11M | -$21M | -$51M | -$73M |
| Tax Expense | $0 | $663K | -$290K | -$157K |
| Net Income | -$11M | -$22M | -$51M | -$73M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $-5.81 | $-11.23 | $-5.19 | $-3.59 |
| EBITDA | -$11M | -$21M | -$48M | -$76M |
| Shares Outstanding | 2M | 2M | 10M | 20M |